Rani Therapeutics Holdings, Inc. (RANI) Tops Q4 EPS by 11c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.27), $0.11 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Adobe (ADBE) PT Raised to $250 at Baird
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'